Kura Oncology (KURA) Capital Expenditures (2014 - 2026)
Kura Oncology's Capital Expenditures came in at $656,000 for Q2 2026, down 55.0% from $1.46 million a year earlier but up 412.5% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Capital Expenditures (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kura Oncology reported Capital Expenditures of $5.67 million, up 167.3% year-over-year; for FY2025, it came in at $6.64 million.
- Capital Expenditures carries a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $472,000 in FY2024 (+181.0%), $168,000 in FY2023 (-73.2%), $626,000 in FY2022 (-45.4%) and $1.15 million in FY2021 (-47.2%).
- The five-year range for quarterly Capital Expenditures is $12,000 (Q4 2022) to $2.57 million (Q3 2025).
- Year-over-year, Capital Expenditures increased in two of the last four quarters, with growth averaging 165.1%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2025 (growth of 523.9%), and the weakest in Q3 2023 (a decline of 94.8%).
- Business Quant data shows KURA's Capital Expenditures at $128,000 (Q1 2026), $2.32 million (Q4 2025) and $2.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Kura Oncology | 952.70 Mn | 952.70 Mn | 20.63 Mn | 656,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656,000.00 |
| Mar 31, 2026 | 128,000.00 |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 381,000.00 |
| Jun 30, 2022 | 184,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Dec 31, 2021 | 102,000.00 |
| Sep 30, 2021 | 723,000.00 |
| Jun 30, 2021 | 291,000.00 |
API Access
Kura Oncology Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();